Linaclotide Acetate

CAS NO.:851199-60-5
Molecular Formula:C61h83n15o23s6
Molecular Weight:1586.78
Fuction:Keeping Health and Promoting Growth
Shelf Life:2 Years
Grade:Medical Grade

Send Inquiry

Description

Linaclotide acetate is a medication that has been developed for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). It belongs to a class of drugs known as guanylate cyclase-C agonists. Here's some information on the efficacy and mechanism of action of linaclotide acetate in treating constipation:

cas 851199-60-5

Clinical Efficacy:

Linaclotide acetate has been shown to be effective in relieving constipation symptoms and improving bowel movements in patients with CIC and IBS-C. Clinical studies have demonstrated that linaclotide acetate can increase the frequency of bowel movements, reduce stool hardness, and alleviate symptoms such as straining and abdominal discomfort.

Mechanism of Action:

Linaclotide acetate works by selectively activating the guanylate cyclase-C receptors in the intestine. This activation leads to an increase in cyclic guanosine monophosphate (cGMP) levels, which in turn stimulates the secretion of chloride and bicarbonate into the intestinal lumen. This secretion helps to increase fluid in the intestines, soften the stool, and improve the overall motility of the digestive system.

Stool Frequency and Consistency:

Linaclotide acetate has been shown to significantly increase the frequency of bowel movements compared to a placebo in clinical trials. It also helps to improve stool consistency, making it easier to pass. These effects contribute to the relief of constipation symptoms and promote regularity in individuals with CIC and IBS-C.

Symptom Relief:

In addition to improving bowel movements, linaclotide acetate has demonstrated efficacy in relieving other symptoms associated with constipation, such as abdominal bloating and discomfort. By enhancing intestinal motility and reducing stool retention, linaclotide acetate can alleviate these symptoms and improve overall gastrointestinal well-being.

Safety and Tolerability:

Linaclotide acetate has generally been well-tolerated in clinical trials. The most commonly reported side effects include diarrhea, abdominal pain, and flatulence. These side effects are usually mild to moderate in severity and tend to diminish over time. It is important to note that linaclotide acetate is contraindicated in individuals with known or suspected mechanical gastrointestinal obstruction.

In conclusion, linaclotide acetate has shown efficacy in the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. By selectively activating guanylate cyclase-C receptors, linaclotide acetate improves bowel movements, stool consistency, and associated symptoms.

Linaclotide acetate

Why choose us?

Our products are raw materials for semi-finished products, mainly sold to enterprises with processing capacity. Products are mainly sold to North America, Europe, South America, Australia and the Middle East and other countries.Thank you for your understanding! If you have any product questions, you can consult us, our business E-mail: sales01@pharchemm.com.

If you need, please feel free to send inquiry to sales01@pharchemm.com.

If there is a quality problem with the product or it does not pass the test, you can rest assured that we have an after-sales guarantee .

img-1772-1772